The first pneumococcal conjugate vaccine (PCV) was licensed more than 25 years ago in the USA and Europe, but its marketing authorisation was based on efficacy studies using a 3+1 dosing regimen, ...

Public health authorities outline who needs which vaccines, organized by age and other key variables—important information ...

(NASDAQ:PCVX) released topline results from the Phase 1/2 study evaluating the safety, tolerability and immunogenicity of VAX ...

I’ve had a pneumovax every year for almost 15 years and I have almost no immunity to 14 of the 23 variants tested, and, of ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

Health officials are expressing concerns that not enough Americans will get vaccinated this year as they recommend getting ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

While economic data may be scarce, every data point gives a new angle to the ever-uncertain economic conditions in the US.

Vaxcyte's stock surges on promising vaccine data, offering potential upside despite competition. Learn more on PCVX here.

Hearing loss affects millions of people, but hearing aids have been expensive and sales have been dominated by a few ...

District Health Department No. 10 will hold vaccination clinics in Crawford County today and Thursday, and in Manistee County ...

Pfizer's recent financial performance shows 14% YoY operational growth excluding COVID sales. Check out more on PFE stock ...